Shopping Cart
Remove All
Your shopping cart is currently empty
EtDO-P4 is a nanomolar inhibitor of sphingolipid (GSL) synthesis, inhibiting EGFR-induced activation of the ERK pathway and various receptor tyrosine kinases (RTK). EtDO-P4 can be used to study a variety of tumor types, including Burkitt's lymphoma.


| Description | EtDO-P4 is a nanomolar inhibitor of sphingolipid (GSL) synthesis, inhibiting EGFR-induced activation of the ERK pathway and various receptor tyrosine kinases (RTK). EtDO-P4 can be used to study a variety of tumor types, including Burkitt's lymphoma. |
| Molecular Weight | 516.76 |
| Formula | C31H52N2O4 |
| Cas No. | 245329-78-6 |
| Smiles | [C@@H]([C@@H](CN1CCCC1)NC(CCCCCCCCCCCCCCC)=O)(O)C=2C=C3C(=CC2)OCCO3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.